CTRI/2019/03/018325Other2 期
A single-blind,Placebo controlled, Randomized Clinical Study of Cosmetic Formulation Acculips - a lipstick with supplements of Iron, Folic acid, Vitamin B12, Vitamin C and Vitamin E for Women - NA
Accuprec Research Labs Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- Other
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Normal healthy human volunteers with/without low haemoglobin, total RBCs should be included.
- •2)Women between the age above 18 to 65 years.
- •3)Patients willing to sign an informed written consent and comply with visit schedules.
- •4)Patients must be able to communicate effectively with study personnel.
排除标准
- •1)Known positive status and known history for diabetes, artificial coloring agents allergy.
- •2)Pregnant or breast feeding women.
- •3)Volunteers should not have any disease. Especially cancer, auto-immune diseases, Rheumatoid arthritis, psoriasis, acidity, peptic ulcers, epilepsy, ulcerative colitis, parkinsonâ??s disease etc. should not be included.
- •4)Subjects on therapy of anti-coagulants, anti-plaelets agents, statins etc. should not be included.
- •5)Subjects having history of/known status of Thyroid gland related problems.
- •6)Subjects consuming excess of vitamin C.
- •7)Subjects following any diet/nutritional programs.
- •8)Subjects who are addicted to smoking or alcohol should not be included.
- •9)Subjects on any other experimental treatment within 07 days of the first dose of study drug or who have not recovered from the side effects of such therapy.
- •10)Patient have history of hospitalized treatment before 07 days.
研究者
相似试验
已完成
1 期
A phase I clinical trial to study the safety and tolerability of multiple doses of a new compound, RBx 10017609, in healthy volunteersCTRI/2009/091/000173Ranbaxy Laboratories Ltd. Plot No. 20, Sector 18 Udyog Vihar Industrial Area Gurgaon 122015. Haryana INDIA42
已完成
1 期
A phase I clinical trial to study the safety and tolerability of a new compound RBx 10017609 in healthy volunteersCTRI/2008/091/000299Ranbaxy Laboratories Ltd76
已完成
不适用
A study to look at the safety and performance of Neuromuscular Electrical Stimulation (NMES) with the NeuroTech Vital device compared to the itouch Sure Pelvic Floor Exerciser for the treatment of stress urinary incontinenceISRCTN27961345Bio-Medical Research Ltd (Ireland)10
已完成
2 期
Clinical study to evaluate the safety and efficacy of ATRICOV 452 for the treatment of COVID-19 along with the standard of care.CTRI/2021/01/030795Atrimed Pharmaceutical Pvt Ltd95
进行中(未招募)
1 期
A study to investigate safety, tolerability, and pharmacokinetics of AZD7503 in healthy Japanese participants.nonalcoholic fatty liver diseaseJPRN-jRCT2071230075Ageishi Yuji12
